Transfer Factor

References

• Landsteiner K., Chase M. W. Experiments on transfer of cutaneous sensitivity to simple chemical compounds. Proc. Soc. Exp. Biol. Med. 1942; 49: 688
   Google Scholar
• Chase M. W. The cellular transfer of cutaneous hypersensitivity to tuberculin. Proc. Soc. Exp. Biol. Med. 1945; 59: 134
   Web of Science ®Google Scholar
• Bloom B. R., Chase M. W. Transfer of delayed-type hypersensitivity: a critical review and experimental study in the guinea pig. Prog. Allergy 1967; 10: 151
   PubMedGoogle Scholar
• Lawrence H. S. The cellular transfer of cutaneous hypersensitivity to tuberculin in man. Proc. Soc. Exp. Biol. Med. 1949; 71: 516
   PubMed Web of Science ®Google Scholar
• Lawrence H. S. The transfer in humans of delayed skin sensitivity to streptococcal M substance and to tuberculin with disrupted leucocytes. J. Clin. Invest. 1955; 34: 219
   PubMed Web of Science ®Google Scholar
• Lawrence H. S., Pappenheimer A. M., Jr. Transfer of delayed hypersensitivity to diphtheria in man. J. Exp. Med. 1956; 104: 321
   PubMed Web of Science ®Google Scholar
• Lawrence H. S. Transfer factor in cellular immunity. The Harvey Lectures (68th series). Academic Press, New York 1974; 239
   Google Scholar
• Bloom B. Does transfer factor act specifically or as an immunologic adjuvant?. N. Engl. J. Med. 1973; 288: 908
   PubMed Web of Science ®Google Scholar
• Kirkpatrick C. H. Properties and activities of transfer factor. J. Allergy Clin. Immunol. 1975; 55: 411
   PubMed Web of Science ®Google Scholar
• Kirkpatrick C. H. Transfer of delayed cutaneous hypersensitivity with transfer factor. Cell Immunol. 1978; 41: 62
   PubMed Web of Science ®Google Scholar
• Levin A. S., Spitler L. E., Stites D. P., Fudenberg H. H. Wiskott-Aldrich syndrome, a genetically determined cellular immunologic deficiency: clinical and laboratory responses to therapy with transfer factor. Proc. Natl. Acad. Sci. U.S.A. 1970; 61: 821
   Google Scholar
• Khan A. Nonspecificity of transfer factor. Ann. Allergy 1977; 38: 320
   PubMedGoogle Scholar
• Du Pont B., Ballow M., Hansen J. A., Quick C., Yunis E. J., Good R. A. Effect of transfer factor therapy on mixed lymphocyte culture reactivity. Proc. Natl. Acad. Sci. U.S.A. 1974; 71: 867
   PubMed Web of Science ®Google Scholar
• Griscelli C., Revillard J. P., Betuel H., Herzog C., Touraine J. L. Transfer factor therapy in immunodeficiencies. Biomedicine 1973; 18: 220
   PubMedGoogle Scholar
• Goldblum R. M., Lord R. A., Dupree E., Weinberg A. G., Goldman A. S. Transfer factor induced delayed hypersensitivity in X-linked combined immunodeficiency. Cell. Immunol. 1973; 9: 297
   PubMed Web of Science ®Google Scholar
• Khan A., Hill J. M., Loeb E., MacLellan A., Hill N. O. Management of Chediak-Higashi syndrome with transfer factor. Am. J. Dis. Child. 1973; 126: 797
   PubMedGoogle Scholar
• Arala-Chaves M. P., Proenĉa R., de Sousa M. Transfer factor therapy in a case of complex immunodeficiency. Cell. Immunol. 1974; 10: 371
   PubMed Web of Science ®Google Scholar
• Valdimarsson H., Hambleton G., Henry K., McConnell I. Restoration of T-lymphocyte deficiency with dialyzable leukocyte extract. Clin. Exp. Immunol. 1974; 16: 141
   PubMed Web of Science ®Google Scholar
• Mendes N. F., Saraiva P. S., Saraiva O. B. O. Restorative effect of normal human serum, transfer factor and thymosin on the ability of heated human lymphocytes to form rosettes with sheep erythrocytes. Cell. Immunol. 1975; 17: 560
   PubMed Web of Science ®Google Scholar
• Valdimarsson H., McGuire R. L. Crude transfer factor preparations stimulate trypsinized human lymphocytes to form rosettes with sheep red cells. Clin. Exp. Immunol. 1977; 29: 261
   PubMed Web of Science ®Google Scholar
• Khan A., Thometz O., Garrison O., Hill J. M. Increase in E-rosettes after transfer factor (TF) treatment: fractionation of TF. Ann. Allergy 1976; 36: 330
   PubMedGoogle Scholar
• Holzman R. S., Schreiber E., Lawrence H. S. Production of sheep erythrocyte rosette forming cells by lymphocytes cultured with leucocyte dialysates. Transfer Factor: Basic Properties and Clinical Applications, M. S. Ascher, A. A. Gottlieb, C. H. Kirkpatrick. Academic Press, New York 1976; 205
   Google Scholar
• Scheinberg M. A., Cathcart E. S., Goldstein A. L. Thymosin-induced reduction of “null cells” in peripheral blood lymphocytes of patients with systemic lupus erythematosus. Lancet 1975; 1: 424
   PubMed Web of Science ®Google Scholar
• Agbata A. I., Kirkpatrick C. H. Release of E-rosette augmenting factor (E-RAF) following stimulation of human leukocytes with mitogens or antigens. J. Immunol 1979; 122: 1080
   PubMed Web of Science ®Google Scholar
• Wybran J., Levin A. S., Spitler L. E., Fodenberg H. H. Rosette-forming cells, immunologic deficiency diseases and transfer factor. N. Engl. J. Med. 1973; 288: 710
   PubMed Web of Science ®Google Scholar
• Gallin J. I., Kirkpatrick C. H. Chemotactic activity in dialyzable transfer factor. Proc. Natl. Acad. Sci. U.S.A. 1974; 71: 498
   PubMed Web of Science ®Google Scholar
• Goetzl E. J., Austen K. F. Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: identification as eosinophil chemotactic factor of anaphylaxis. Proc. Natl. Acad. Sci. U.S.A. 1972; 72: 4123
   Google Scholar
• Sandler J. A., Smith T. K., Manganiello V. C, Kirkpatrick C. H. Stimulation of monocyte cGMP by leukocyte dialysates. J. Clin. Invest. 1975; 56: 1271
   PubMed Web of Science ®Google Scholar
• Kirkpatrick C. H., Smith T. K. The nature of transfer factor and its clinical efficacy in the management of cutaneous disorders. J. Invest. Dermatol. 1976; 67: 425
   PubMed Web of Science ®Google Scholar
• Togawa A., Oppenheim J. J., Kirkpatrick C. H. Ability of dialysates containing transfer factor to induce lymphocyte activating factor by human mononuclear cells. Cell. Immunol. 1979; 45: 133
   PubMed Web of Science ®Google Scholar
• Hamblin A. S., Dumonde D. C., Maini R. N. Human transfer factor in vitro. II. Augmentation of lymphocyte transformation to phytohaemagglutinin. Clin. Exp. Immunol. 1976; 23: 303
   Web of Science ®Google Scholar
• Burger D. R., Vandenbark A. A., Finke P., Nolte J. E., Vetto R. M. Human transfer factor: effects on lymphocyte transformation. J. Immunol. 1976; 117: 782
   PubMed Web of Science ®Google Scholar
• Burger D. R., Vandenbark A. A., Daves D., Anderson W. A., Vetto R. M., Finke P. Nicotinamide: suppression of lymphocyte transformation with a component identified in human transfer factor. J. Immunol. 1976; 177: 797
   Google Scholar
• Khan A., Antonetti A., Burt S. L. F., Hill J. M. Induction of cortisone resistance and increased mitogen responsiveness in thymocytes by transfer factor (TF), in Immune Regulators in Transfer Factor, A. Khan, C. H. Kirkpatrick, N. O. Hill. Academic Press, New York 1979, in press
   Google Scholar
• Huard T. K., Sabet T., Baram P. In vivo effects of dialyzable leukocyte lysates (DLL): changes in the responses of murine spleen cells to T- and B-cell mitogens, spleen weight, and morphology of splenic tissue. Clin. Immunol. Immunopathol. 1978; 11: 229
   PubMedGoogle Scholar
• Anderson A. O., Ascher M. S., Andron L. A. Adjuvant effects of dialyzable leukocyte extracts on immunity to killed viral vaccine. Lab. Invest. 1977; 36: 354, abst.
   Web of Science ®Google Scholar
• Anderson A. O. Discussion of paper by Huard and Baram, in Transfer Factor: Basic Properties and Clinical Applications, M. S. Ascher, A. A. Gottlieb, C. H. Kirkpatrick. Academic Press, New York 1976; 370
   Google Scholar
• Spitler L. E., Levin A. S., Fudenberg H. H. Human lymphocyte transfer factor. Methods in Cancer Research, H. Busch. Academic Press, New York 1973; 59, Vol. 8
   Google Scholar
• Kirkpatrick C. H., Smith T. K. Chronic mucocutaneous candidiasis: immunologic and antibiotic therapy. Ann. Intern. Med. 1974; 80: 310
   PubMed Web of Science ®Google Scholar
• Catanzaro A., Spitler L. Clinical and immunological results of transfer therapy in coccidioidomycosis. Transfer Factor: Basic Properties and Clinical Applications, M. S. Ascher, A. A. Gottlieb, C. H. Kirkpatrick. Academic Press, New York 1976; 447
   Google Scholar
• Rapaport F. T., Lawrence H. S., Millar J. W., Pappagianis D., Smith C. E. Transfer of delayed hypersensitivity to coccidioidin in man. J. Immunol. 1960; 84: 358
   PubMed Web of Science ®Google Scholar
• Brandriss M. W. Attempt to transfer contact hypersensitivity in man with dialysate of peripheral leukocytes. J. Clin. Invest. 1968; 47: 2152
   PubMed Web of Science ®Google Scholar
• Arala-Chaves M. P., Pinto A. S. Transfer factor with dinitrochlorobenzene. Int. Arch. Allergy Appl. Immunol. 1972; 43: 410
   PubMedGoogle Scholar
• Maurer P. H. Immunologic studies with ethylene oxide-treated human serum. J. Exp. Med. 1961; 113: 1029
   PubMed Web of Science ®Google Scholar
• Zuckerman K. S., Neidhart J. A., Balcerzak S. P., LoBuglio A. F. Immunologic specificity of transfer factor. J. Clin. Invest. 1974; 54: 997
   PubMed Web of Science ®Google Scholar
• Burger D. R., Vandenbark A. A., Finke P., Vetto R. M. De novo appearance of KLH transfer factor following immunization. Cell. Immunol. 1977; 29: 410
   PubMed Web of Science ®Google Scholar
• Kirkpatrick C. H., Smith T. K. Serial transfer of delayed hypersensitivity with dialyzable transfer factor. Cell. Immunol. 1976; 27: 323
   PubMed Web of Science ®Google Scholar
• Epstein W. L., Byers V. S. Transfer of contact sensitivity to beryllium using dialysable leukocyte extracts (Transfer Factor). J. Allergy Clin. Immunol. 1979; 63: 111
   PubMed Web of Science ®Google Scholar
• Eichberg J. W., Steele R. W., Kalter S. S., Kniker W. T., Heberling R. L., Eller J., Jr., Rodriquez A. R. Cellular immunity in gnotobiotic primates induced by transfer factor. Cell. Immunol. 1976; 26: 114
   PubMed Web of Science ®Google Scholar
• Kirkpatrick C. H., Rich R. R., Smith T. K. Effects of transfer factor on lymphocyte function in anergic patients. J. Clin. Invest. 1972; 51: 2948
   PubMed Web of Science ®Google Scholar
• Spitler L. E., Levin A. S., Stites D. P., Fudenberg H. H., Pirofsky B., August C. S., Stiehm R., Hitzig W. H., Gatti R. A. The Wiskott-Aldrich Syndrome. Results of transfer factor therapy. J. Clin. Invest. 1972; 51: 3216
   PubMed Web of Science ®Google Scholar
• Paque R. E., Kniskern P. J., Dray S., Baram P. In vitro studies with transfer factor: transfer of the cell-migration inhibition correlate of delayed hypersensitivity in humans with cell lysates from humans sensitized to histoplasmin, coccidioidin or PPD. J. Immunol. 1969; 103: 1014
   PubMed Web of Science ®Google Scholar
• Paque R. E., Dray S., Kniskern P., Baram P. In vitro studies with transfer factor. Cell Immunol. 1973; 6: 368
   PubMedGoogle Scholar
• Thor D. E., Dray S. Conversion of human nonsensitive lymph node cells to sensitive cells with RNA extract. J. Immunol. 1968; 101: 369
   Web of Science ®Google Scholar
• Rifkind D., Frey J. A., Petersen E. A., Dinowitz M. Delayed hypersensitivity to fungal antigens in mice. II. Molecular classes in immunogenic RNA extracts that transfer delayed hypersensitivity. J. Infect. Dis. 1976; 133: 523
   PubMed Web of Science ®Google Scholar
• Rifkind D., Frey J. A., Petersen E. A., Dinowitz M. Delayed hypersensitivity to fungal antigens in mice. III. Characterization of the active component in immunogenic RNA extracts. J. Infect. Dis. 1976; 133: 533
   PubMed Web of Science ®Google Scholar
• Salaman M. R. Studies on the transfer of delayed hypersensitivity. Immunology 1974; 26: 1069
   PubMedGoogle Scholar
• Dabrowska B., Hamblin A., Dumonde D. Potentiating effect of transfer factor upon macrophage migration inhibition in vitro. Transfer Factor: Basic Properties and Clinical Applications, M. S. Ascher, A. A. Gottlieb, C. H. Kirkpatrick. Academic Press, New York 1976; 147
   Google Scholar
• Newell R. T., Wilson G. B., Reddick L., Burdash N. M., Fudenberg H. H., Bahn V. J., Klesius P. H. In vitro effects of bovine dialyzable leukocyte extracts on human cell mediated immunity. Immune Regulators in Transfer Factor, A. Khan, C. H. Kirkpatrick, N. O. Hill. Academic Press, New York 1979; 161
   Google Scholar
• Levin A. S., Byers V. S., Fundenberg H. H., Wybran J., Hackett A. J., Johnston J. O., Spitler L. E. Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor specific transfer factor. J. Clin. Invest. 1975; 55: 487
   PubMed Web of Science ®Google Scholar
• Bullock W. E., Fields J. P., Brandriss M. W. An evaluation of TF as immunotherapy for patients with lepromatous leprosy. N. Engl. J. Med. 1972; 287: 1053
   PubMed Web of Science ®Google Scholar
• Catanzaro A., Spitler L. E., Moser K. M. Immunotherapy of coccidioidomycosis. J. Clin. Invest. 1974; 54: 690
   PubMed Web of Science ®Google Scholar
• Ascher M. S., Schneider W. J., Valentine F. T., Lawrence H. S. In vitro properties of leucocyte dialysates containing transfer factor. Proc. Natl. Acad. Sci. U.S.A. 1974; 71: 1178
   PubMed Web of Science ®Google Scholar
• Cohen L., Holzman R. S., Valentine F. T., Lawrence H. S. Requirement of precommitted cells as target for the augmentation of lymphocyte proliferation by leucocyte dialysates. J. Exp. Med. 1976; 143: 791
   PubMed Web of Science ®Google Scholar
• Hamblin A. S., Maini R. N., Dumonde D. C. Human transfer factor in vitro I. Augmentation of lymphocyte transformation to tuberculin PPD. Clin. Exp. Immunol. 1976; 23: 290
   Web of Science ®Google Scholar
• Littman B. H., Hirschman E. M., David J. R. Augmentation of 3H-thymidine incorporation by human lymphocytes in the presence of antigen and fractions of dialysable transfer factor: a nonspecific phenomenon. Cell. Immunol. 1977; 28: 158
   PubMed Web of Science ®Google Scholar
• Salaman M. R. An investigation into the antigen-specificity of transfer factor in its stimulatory action on lymphocyte transformation. Immunology 1978; 35: 247
   PubMed Web of Science ®Google Scholar
• Uotila A., Hamblin A., Dumonde D. C, Krohn K. J. E. The effect of transfer factor on lymphocyte transformation. Comparison of augmentation by dialysates of leukocytes and lymphoid and nonlymphoid organs. Int. Arch. Allergy Appl. Immunol. 1978; 57: 210
   PubMedGoogle Scholar
• Ascher M. S., Andron L. A. In vitro properties of leukocyte dialysates containing transfer factor: micro-method and recent findings. Transfer Factor: Basic Properties and Clinical Applications Ascher, S. M, A. A. Gottlieb, C. H. Kirkpatrick. Academic Press, New York 1976; 3
   Google Scholar
• Hamblin A., Maini R. N., Dumonde D. C. Augmentation of lymphocyte transformation by dialysable transfer factor. Transfer Factor: Basic Properties and Clinical Applications, M. S. Ascher, A. A. Gottlieb, C. H. Kirkpatrick. Academic Press, New York 1976; 49
   Google Scholar
• Gelfand E. W., Baumal R., Huber J., Crookston M. C, Shumak K. H. Polyclonal gammopathy and lymphoproliferation after transfer factor in severe combined immunodeficiency disease. N. Engl. J. Med. 1973; 289: 1385
   PubMed Web of Science ®Google Scholar
• Radl J., Dooren L. J., Morel] A., Skvaril F., Vossen J. M. J., Jr., Uittenbogaart C. H. Immunoglobulins and transient paraproteins in sera of patients with the Wiskott-Aldrich syndrome: a follow-up study. Clin. Exp. Immunol. 1976; 25: 256
   PubMed Web of Science ®Google Scholar
• Silverman M. A., Meltz S., Sorokin C, Glade P. R. Effects of transfer factor in Waldenstrom's macroglobulinemia and multiple myeloma. Transfer Factor: Basic Properties and Clinical Applications, M. S. Ascher, A. A. Gottlieb, C. H. Kirkpatrick. Academic Press, New York 1976; 633
   Google Scholar
• Andron L. A. Enzyme-linked immunosorbent assay of antibody levels in guinea pigs given antigen plus transfer factor. Fed. Proc 1978; 37: 1587, Abstr.
   Google Scholar
• Baram P., Mosko M. M. Chromatography of the human tuberculin delayed-type hypersensitivity transfer factor. J. Allergy 1962; 33: 498
   PubMedGoogle Scholar
• Baram P., Yuan L., Mosko M. M. Studies on the transfer of human delayed type hypersensitivity. J. Immunol. 1966; 97: 407
   PubMed Web of Science ®Google Scholar
• Arala-Chaves M. P., Lebacq E. G., Heremans J. F. Fractionation of human leukocyte extracts transferring delayed hypersensitivity to tuberculin. Int. Arch. Allergy Appl. Immunol. 1967; 31: 353
   PubMedGoogle Scholar
• Gottlieb A. A., Foster L. G., Waldman S. R., Lopez M. What is transfer factor?. Lancet 1973; 2: 822
   PubMed Web of Science ®Google Scholar
• Neidart J. A., Schwartz R., Hurtubise P., Murphy S., Metz E., Balcerzak S., Lo Buglio A. Transfer factor: isolation of a biologically active component. Cell. Immunol. 1973; 9: 319
   PubMed Web of Science ®Google Scholar
• Krohn K., Uotila A., Vaisanen J., Grohn P. Studies on the chemical composition and biological properties of transfer factor. Z. Immuno. Forsch. 1977; 153: 395
   Google Scholar
• O'Dorisio M. S., Neidhart J. A., Lo Buglio A. F. Identification fo hypoxanthine as the major component of chromatograhically prepared transfer factor. Transfer Factor: Basic Properties and Clinical Applications, M. S. Ascher, A. A. Gottlieb, C. H. Kirkpatrick. Academic Press, New York 1976; 215
   Google Scholar
• Kirkpatrick C. H., Robinson L. B., Smith T. K. The identification and significance of hypoxanthine in dialysable transfer factor. Cell. Immunol. 1976; 24: 230
   PubMed Web of Science ®Google Scholar
• Tomar R. H. Transfer factor ? some biochemical observations. Transfer Factor: Basic Properties and Clinical Applications, M. S. Ascher, A. A. Gottlieb, C. H. Kirkpatrick. Academic Press, New York 1976; 229
   Google Scholar
• Wilson G. B., Welch T. M., Knapp D. R., Horsmanheimo A., Fudenberg H. H. Characterization of Tx, an active subfraction of human dialyzable transfer factor. I. Identification of the major component in TFg, a precursor of Tx, as hypoxanthine, C//n. Immunol. Immunopathol. 1977; 8: 551
   PubMedGoogle Scholar
• Vandenbark A. A., Burger D. R., Dryer D. L., Daves G. D., Vetto R. M. Human transfer factor: fractionation by electrofocusing and high pressure, reverse phase chromatography. J. Immunol. 1977; 118: 636
   PubMed Web of Science ®Google Scholar
• Burger D. R, Wampler P. A., Vandenbark A. A., Vetto R. M. A structural model for human transfer factor suggested by enzymatic susceptibilities. Immune Regulators in Transfer Factor, A. Khan, C. H. Kirkpatrick, N. O. Hill. Academic Press, New York 1979; 377
   Google Scholar
• Rifkind D., Frey J. A., Peterson E. A., Dinowitz M. Transfer of delayed hypersensitivity in mice to microbial antigens with dialyzable transfer factor. Infect. Immunol. 1977; 16: 258
   PubMed Web of Science ®Google Scholar
• Paddock G., Wilson G. B., Fudenberg H. H., Wang A-C, Lovins R. E. Purification and structural analyses of the transfer factor (TF)-like activity detected in vitro by leukocyte migration inhibition (LMI). Immune Regulators in Transfer Factor, A. Khan, C. H. Kirkpatrick, N. O. Hill. Academic Press, New York, in press
   Google Scholar
• Lewis D. E., Cramer J. D., Reed R. E. Detection of a new protein component in canine plasma after transfer factor administration: correlation with delayed-type skin reactivity. Immune Regulators in Transfer Factor, A. Khan, C. H. Kirkpatrick, N. O. Hill. Academic Press, New York, in press
   Google Scholar
• Khan A., Garrison O., Thometz D., Hill J. M. Fractionation of transfer factor with high pressure liquid chromatography and E-rosette enhancing activity of various fractions. Transfer Factor: Basic Properties and Clinical Applications, M. S. Ascher, A. A. Gottlieb, C. H. Kirkpatrick. Academic Press, New York 1976; 335
   Google Scholar
• Kirkpatrick C. H., Smith T. K. Specific and nonspecific activities in dialyzable transfer factor. Regulatory Mechanisms In Lymphocyte Activation, D. O. Lucas. Academic Press, New York 1977; 174
   Google Scholar
• Jeter W. S., Tremaine M. M., Seebohm P. M. Passive transfer of delayed hypersensitivity to 2,4-dinitrochlorobenzene in guinea pigs with Ieucocytic extracts. Proc. Soc. Exp. Biol. Med. 1954; 86: 251
   PubMed Web of Science ®Google Scholar
• Jeter W. S., Laurence K. A., Seebohm P. M. Analysis of leukocytic extracts from guinea pigs hypersensitive to tuberculin and 2,4-dinitrochlorobenzene. J. Bacteriol. 1957; 74: 680
   PubMed Web of Science ®Google Scholar
• Burger D. R., Jeter W. S. Cell-free passive transfer of delayed hypersensitivity to chemicals to guinea pigs. Infect, Immun. 1971; 4: 575
   PubMed Web of Science ®Google Scholar
• Burger D. R., Vetto R. M., Malley A. Transfer factor from guinea pigs sensitive to dinitroch-lorobenzene. Absence of super-antigen properties. Science 1972; 1975: 1473
   Google Scholar
• Welch T. M., Triglia R., Spitler L. E., Fudenberg H. H. Preliminary studies on human “transfer factor” activity in guinea pigs. Clin. Immunol. Immunopathol. 1976; 5: 407
   PubMedGoogle Scholar
• Vandenbark A. A., Burger D. R., Vetto R. M. Human transfer factor activity in the guinea pig: absence of specificity. Clin. Immunol. Immunopathol. 1977; 8: 7
   PubMedGoogle Scholar
• Dunnick W., Bach F. H. Guinea pig transfer factor-like activity detectedin vitro. Proc. Natl. Acad. Sci. U.S.A. 1975; 72: 4573
   PubMed Web of Science ®Google Scholar
• Maddison S. E., Hicklin M. D., Conway B. P., Kagan I. G. Transfer factor: delayed hypersensitivity to Schistosoma mansoniand tuberculin in Macaca mulatta. Science 1972; 178: 757
   PubMed Web of Science ®Google Scholar
• Zanelli J. M., Adler W. H. Transfer factor-transfer of tuberculin cutaneous sensitivity in an allogeneic and xenogeneic monkey model. Cell. Immunol. 1975; 15: 475
   PubMed Web of Science ®Google Scholar
• Mazaheri R., Zuckerman A., Hamblin A., Dumonde D. Specificity determinants of DTF in the rhesus monkey model. Immune Regulators in Transfer Factor, A. Khan, C. H. Kirkpatrick, N. O. Hill. Academic Press, New York 1979; 65
   Google Scholar
• Shifrine M., Thilsted J., Pappagianis D. Canine transfer factor. Transfer Factor: Basic Properties and Clinical Applications, M. S. Ascher, A. A. Gottlieb, C. H. Kirkpatrick. Academic press, New York 1976; 349
   Google Scholar
• Simon M. R., Silva J., Freier D., Bruner J., Williams R. Tuberculin-specific transfer factor in dogs. Infect. Immun. 1977; 18: 73
   PubMed Web of Science ®Google Scholar
• Tomar R. H., Terzian J. Reactions in canine skin with human leukocyte lysates. Proc. Soc. Exp. Biol. Med. 1977; 156: 247
   PubMed Web of Science ®Google Scholar
• Klesius P. H., Kristensen F., Ernst J. V., Kramer T. T. Bovine transfer factor: isolation and characteristics. Transfer Factor: Basic Properties and Clinical Applications, M. S. Ascher, A. A. Gottlieb, C. H. Kirkpatrick. Academic Press, New York 1976; 311
   Google Scholar
• Klesius P. H., Fudenberg H. H.M. Bovine transfer factor: in vivo transfer of cell-mediated immunity to cattle with alcohol precipitates. Clin. Immunol. Immunopathol. 1977; 8: 238
   PubMedGoogle Scholar
• Klesius P. H., Kristensen F. Bovine transfer factor: effect on bovine and rabbit coccidiosis. Clin. Immunol. Immunopathol. 1977; 7: 240
   PubMedGoogle Scholar
• Klesius P. H., Quail D. F., Elston A. L., Fudenberg H. H. Effects of bovine transfer factor (TFd) in mouse coccidiosis (Eimeria ferrisi). Clin. Immunol, l-munopathol. 1978; 10: 214
   PubMedGoogle Scholar
• Liburd E. M., Pabst H. F., Armstrong W. D. Transfer factor in rat coccidiosis. Cell. Immu-no/. 1972; 5: 487
   PubMed Web of Science ®Google Scholar
• Petersen E. A., Frey J. A., Dinowitz M., Rifkind D. Transfer of delayed hypersensitivity to mice with human immune cell extracts. Transfer Factor: Basic Properties and Clinical Applications, M. S. Ascher, A. A. Gottlieb, C. H. Kirkpatrick. Academic Press, New York 1976; 387
   Google Scholar
• Basten A., Croft S., Edwards J. Experimental studies of transfer factor. Transfer Factor: Basic Properties and Clinical Applications, M. S. Ascher, A. A. Gottlieb, C. H. Kirkpatrick. Academic Press, New York 1976; 75
   Google Scholar
• Klesius P. H. Bovine dialyzable transfer factor: stimulation of antigen-specific DTH in C57 B1 mice. Immune Regulators in Transfer Factor, A. Khan, C. H. Kirkpatrick, N. O. Hill. Academic Press, New York 1979; 43
   Google Scholar
• Brummer E., Bhardwaj N., Foster L. G., Lawrence H. S. A murine model for studying the transfer of DTH with human TFd and murine TFd. Immune Regulators in Transfer Factor, A. Khan, C. H. Kirkpatrick, N. O. Hill. Academic Press, New York 1979; 27
   Google Scholar
• Rifkind D., Frey J. A., Dinowitz M. Susceptibility of murine transfer factor to dimerized ribonuclease A. Infect. Immun. 1977; 16: 922
   Web of Science ®Google Scholar
• Buraet M. Transfer factor — a theoretical discussion. J. Allergy. Clin. Immunol. 1974; 54: 1
   PubMed Web of Science ®Google Scholar
• Basten A, Crofts S. Transfer factor, clinical usage and experimental studies. Immunological Engineering, B. W. Jirsch. University Park Press, Baltimore 1978; 83
   Google Scholar
• Pachman L. M., Kirkpatrick C. H., Kaufman D. H., Rothberg R. M. The lack of effect of TF in thymic displasia with immunoglobulin synthesis. J. Pediatr. 1974; 84: 681
   PubMed Web of Science ®Google Scholar
• Ammann A. J., Wara D., Salmon S. Transfer factor: therapy in patients with deficient cell-mediated immunity and deficient antibody-mediated immunity. Cell. Immunol. 1974; 12: 94
   PubMed Web of Science ®Google Scholar
• Strauss R. G., Hake D. A. Combined immunodeficiency disease with response to transfer factor. J. Pediatr. 1974; 85: 680
   PubMed Web of Science ®Google Scholar
• Levin A. S., Spitler L. E., Fudenberg H. H. Transfer factor therapy in immune deficiency states. Annu. Rev. Med. 1973; 24: 175
   PubMed Web of Science ®Google Scholar
• Spitler L. E. Transfer factor therapy in the Wiskott-Aldrich syndrome. Results of long-term follow-up in 32 patients. Am. J. Med. 1979; 67: 59
   PubMed Web of Science ®Google Scholar
• Berkel A. I., Ersoy F., Epstein L. B., Spitler L. E. Transfer factor therapy in ataxia-telangiectasia. Clin. Exp. Immunol. 1977; 29: 376
   PubMed Web of Science ®Google Scholar
• Silverman M., Meltz S., Yanovich S., Sorokin C, Glade P. Transfer factor in the treatment of B-cell disorders: effects and potential risks. Immune Regulators in Transfer Factor, A. Khan, C. H. Kirkpatrick, N. O. Hill. Academic Press, New York 1979; 471
   Google Scholar
• Hiss P. H., Zinsser H. Experimental and clinical studies on the curative action of leukocyte extracts in infections. J. Med. Res. 1908; 19: 323
   PubMedGoogle Scholar
• Grob P. J., Reymond J. F., Hacki M. A., Frey-Wettstein M. Some physiochemical and biological properties of a transfer factor preparation and its clinical application. Transfer Factor: Basic Properties and Clinical Applications, M. S. Ascher, A. A. Gottlieb, C. H. Kirkpatrick. Academic Press, New York 1976; 247
   Google Scholar
• Fudenberg H. H., Levin A. S., Spitler L. E., Wybran J., Byers V. The therapeutic uses of transfer factor. Hosp. Pract. January, 1974; 95
   Web of Science ®Google Scholar
• Kirkpatrick C. H., Smith T. K. Chronic mucocutaneous candidiasis: immunologic and antibiotic therapy. Ann. Intern. Med. 1974; 80: 310
   PubMed Web of Science ®Google Scholar
• Littman B. H., Rocklin R. E., Parkman R., David J. R. Combination transfer factor-amphotericin B therapy in a case of chronic mucocutaneous candidiasis: a controlled study. Transfer Factor: Basic Properties and Clinical Applications, M. S. Ascher, A. A. Gottlieb, C. H. Kirkpatrick. Academic Press, New York 1976; 495
   Google Scholar
• Kirkpatrick C. H., Greenberg L. E. Treatment of chronic mucocutaneous candidiasis with transfer factor. Immune Regulators in Transfer Factor, A. Khan, C. H. Kirkpatrick, N. O. Hill. Academic Press, New York 1979; 547
   Google Scholar
• Drutz D. J., Catanzaro A. Coccidoidomycosis. Am. Rev. Respir. Dis. 1978; 117: 727
   PubMedGoogle Scholar
• Mittal M. M., Sana K., Maheswari H. B. Passive transfer of immunity in lepromatous leprosy patients by Lawrence's transfer factor. J. Indian Med. Assoc. 1976; 6: 197
   Google Scholar
• Hastings R. C, Morales M. J., Shannon E. J., Jacobson R. R. Preliminary results on the safety and efficacy of transfer factor in leprosy. Transfer Factor: Basic Properties and Clinical Applications, M. S. Ascher, A. A. Gottlieb, C. H. Kirkpatrick. Academic Press, New York 1976; 465
   Google Scholar
• Emodi G., Just M., Grob P. Circulating interferon after transfer factor therapy. Lancet 1973; 2: 1382
   PubMed Web of Science ®Google Scholar
• Khan A. Transfer factor in viral diseases. Lancet 1978; 1: 328
   PubMed Web of Science ®Google Scholar
• Kohler P. F., Tremblath J., Merrill D. A., Singleton J. W., Dubois R. S. Immunotherapy with antibody, lymphocytes and transfer factor in chronic hepatitis B. Clin. Immunol. Immuno-pathol. 1974; 2: 465
   Google Scholar
• Tong M. J., Mystrom J. S., Redeker A. G., Marshall G. J. Failure of TF therapy in chronic active type B hepatitis. N. Engl. J. Med. 1976; 295: 209
   PubMedGoogle Scholar
• Antunes L. J. Treatment of chronic aggressive hepatitis: corticosteroids or transfer factor?, personal communication
   Google Scholar
• Jain S., Thomas H. C, Sherlock S. Transfer factor in the attempted treatment of patients with HBs Ag-positive chronic liver disease. Clin. Exp. Immunol. 1977; 30: 10
   PubMed Web of Science ®Google Scholar
• Shulman S. T., Hutto J. H., Scott B., Ayoub E. M., McGuigan J. E. Transfer factor therapy of chronic aggressive hepatitis. Transfer Factor: Basic Properties and Clinical Applications, M. S. Ascher, A. A. Gottlieb, C. H. Kirkpatrick. Academic Press, New York 1976; 439
   Google Scholar
• Moulias R., Goust J. M., Reinert P., Fournel J. J., Deville-Chabrolle A., Dnoug N., Muller-Berat C. N., Berthaux P. Facteur de transfert de l'immunite cellulaire. Nouv. Presse Med. 1973; 2: 1341
   Google Scholar
• Moulias R., Hainaut J., Reinert P., Vignat J., Lesourd B., Marescot M. R. Transfer factor therapy in viral diseases. Results, adverse effects; indications. Immune Regulators in Transfer Factor, A. Khan, C. H. Kirkpatrick, N. O. Hill. Academic Press, New York 1979; 521
   Google Scholar
• Peetoom F., Florey M. J. Transfer factor (HZLTF) in treatment of disseminated Herpes zoster (AZ) in immune suppressed patients. Immune Regulators in Transfer Factor, A. Khan, C. H. Kirkpatrick, N. O. Hill. Academic Press, New York 1979; 489
   Google Scholar
• Khan A., Nagata, Hill N. O., Hansen B., Antonetti A., Hill J. M., Pardue A. S., Loeb E., Hill N. O. Management of viral infections with transfer factor. Immune Regulators in Transfer Factor, A. Khan, C. H.Hill Kirkpatrick, N. O. Eds. Academic Press, New York, in press
   Google Scholar
• Heim L. R. Atopic dermatitis, specific virus and Behcet's syndrome transfer factor therapy. Immune Regulators in Transfer Factor, A. Khan, C. H. Kirkpatrick, N. O. Hill. Academic Press, New York, in press
   Google Scholar
• Stevens D. A., Ferrington R. A., Merigan T., Marinkovich V. A. Randomised trial of transfer factor treatment of human warts. Clin. Exp. Immunol. 1975; 21: 520
   PubMed Web of Science ®Google Scholar
• Quick C. A., Behrens H. W., Brinton-Darnell M., Good R. A. Treatment of papillomatosis of the larynx with transfer factor. Ann. Otol. Rhinol. LaryngoL 1975; 84: 607
   PubMed Web of Science ®Google Scholar
• Steele R. W., Heberling L., Eichberg J. W., Eller J. J., Kalter S. S., Kniker W. T. Prevention of herpes simplex virus type 1 fatal dissemination in primates with human transfer factor. Transfer Factor: Basic Properties and Clinical Applications, M. S. Ascher, A. A. Gottlieb, C. H. Kirkpatrick. Academic Press, New York 1976; 381
   Google Scholar
• Sharma M., Momtaz A., Firouz R., Ala F. Transfer factor therapy of human cutaneous leishmania infection (CLI). A double blind clinical trial. Immune Regulators in Transfer Factor, A. Khan, C. H. Kirkpatrick, N. O. Hill. Academic Press, New York 1979; 563
   Google Scholar
• Strannegard I. L., Hanson L. A., Lindholm L., Mobacken H., Strannegard O. Transfer factor in severe atopic disease. Lancet 1975; 2: 702
   PubMed Web of Science ®Google Scholar
• Khan A., Sellars W., Grater W.t, Graham M. F., Pflanzer J., Antonetti A., Bailey J., Hill N. O. The usefulness of transfer factor in asthma associated with frequent infections. Ann. Allergy 1978; 40: 229
   PubMedGoogle Scholar
• Wolf R. E., Fudenberg H. H., Welch T. M., Spitler L. E., Ziff M. Treatment of Behcet's syndrome with transfer factor. JAMA 1977; 238: 869
   PubMed Web of Science ®Google Scholar
• Rodriquez G. E., Cooke C. L., Thomas J. Treatment of Behcet's syndrome with transfer factor. Immune Regulators in Transfer Factor, A. Khan, C. H. Kirkpatrick, N. O. Hill. Adacemic Press, New York 1979; 537
   Google Scholar
• Maini R. N., Scott J. T., Hamblin A., Roffe L., Dumonde D. C. Is the clinical benefit from transfer factor in rheumatoid arthritis a placebo effect? in. Transfer Factor: Basic Properties and Clinical Applications, M. S. Ascher, A. A. Gottlieb, C. H. Kirkpatrick. Academic Press, New York 1976; 601
   Google Scholar
• Hoyeraal H. M., Froland S. S., Slavesen C. F., Munthe E., Natvig J. B., Kass E., Blichfeldt P., Hegna T. M., Revlem E. No effect of transfer factor in juvenile rheumatoid arthritis by double-blind trial. Ann. Rheum. Dis. 1978; 37: 197
   Google Scholar
• Behan P. O., Melville I. D., Durward W. F., McGeorge A. P., Behan W. M. H. Transfer factor therapy in multiple sclerosis. Lancet 1976; 1: 988
   PubMedGoogle Scholar
• Fog T., Pedersen L., Raun N. E., Kam-Hansen S., Mellerup E., Platz P., Ryder L. P., Jakob-Sen B. K., Grob P. Long-term transfer factor treatment for multiple sclerosis. Lancet 1978; 1: 851
   PubMed Web of Science ®Google Scholar
• Collins R. C, Espinoza L. R., Plank C. R., Ebers G. C, Rosenberg R. A., Zabriskie J. B. A double-blind trial of transfer factor vs placebo in multiple sclerosis patients. Clin. Exp. Immunol. 1978; 33: 1
   PubMed Web of Science ®Google Scholar
• Walker A. M., Garcia R., Pate P., Mata L. J., David J. R. Transfer factor in the immune deficiency of protein-calorie malnutrition: a controlled study with 32 cases. Cell. Immunol. 1975; 15: 372
   PubMed Web of Science ®Google Scholar
• Jose D. G., Ford G. W., Welch J. S. Therapy with parents lymphocyte TF in children with infection and malnutrition. Lancet 1976; 1: 263
   PubMed Web of Science ®Google Scholar
• Byers V. E., Levin A. S., Le Cam L., Johnston J. O., Hackett A. J. Tumor-specific transfer factor therapy in osteogenic sarcoma: a two-year study. Ann. N. Y. Acad. Sci. 1976; 277: 621
   PubMed Web of Science ®Google Scholar
• Ritts R. E., Pritchard D. J., Taylor W. F., Gilchrist G. S., Ivins J. C. Comparison of transfer factor and combination chemotherapy as post-surgical adjuvants in osteogenic sarcoma: results of three years. Immunotherapy of Malignant Diseases, H. Rainer. S. K. Schattauer Verlag, New York 1978; 343
   Google Scholar
• Meir C. R., Lo Buglio A. F. Transfer factor: a potential agent for immunotherapy of cancer. World J. Surg. 1977; 1: 617
   PubMedGoogle Scholar
• Pizza G., Viza D., Wood J., Boucheix C, Corrado F. Some observations with in vitro produced transfer factor. Immune Regulators in Transfer Factor, A. Khan, C. H. Kirkpatrick, N. O. Hill. Academic Press, New York 1979; 323
   Google Scholar
• Vetto R. M., Burger D. R., Nolte J. E., Vandenbark A. E., Baker H. W. Transfer factor therapy in patients with cancer. Cancer (Philadelphia) 1976; 37: 90
   PubMed Web of Science ®Google Scholar
• Ballow M., Dupont B., Good R. A. Autoimmune hemolytic anemia in Wiskott-Aldrich syndrome during treatment with transfer factor. J. Pediatr. 1973; 83: 772
   PubMed Web of Science ®Google Scholar
• Ballow M., McLean R., Kamjanov I., Lowenstein M. Autoimmunity, changes in B-cell function and transfer factor therapy. Immune Regulators in Transfer Factor, A. Khan, C. H. Kirkpatrick, N. O. Hill. Academic Press, New York 1979; 731
   Google Scholar
• Chapman S. W., Kirkpatriclc C. H. 1980, unpublished
   Google Scholar
• Olarte M. R., Gersten J. C, Zabriskie J., Rowland L. P. Transfer factor is ineffective in amyotropic lateral sclerosis. Ann. Neurol. 1979; 5: 385
   PubMed Web of Science ®Google Scholar